Kartesada

Pregabalin, the active ingredient in Kartesada, is an anticonvulsant presented as an oral tablet for systemic use. It is prescribed to manage neuropathic pain, partial seizures and generalized anxiety disorder in adult patients. The medication works by modulating calcium channel activity to reduce excitatory neurotransmitter release.

GNH USA supplies Kartesada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures consistent quality and regulatory compliance across EU and global markets. We adhere to stringent quality standards and provide comprehensive documentation for each shipment.

Pregabalin is used to treat several neuropathic and seizure disorders by targeting abnormal neuronal excitability.

Diabetic peripheral neuropathic pain: reduces pain intensity and improves functional status. Postherpetic neuralgia: alleviates burning and shooting pain after shingles. Fibromyalgia: decreases widespread musculoskeletal pain and improves sleep quality. Partial onset seizures: provides adjunctive control of focal seizures in adults. Generalized anxiety disorder: lessens anxiety symptoms and improves daily functioning.

Pregabalin may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dizziness - Somnolence - Peripheral edema - Weight gain - Dry mouth - Blurred vision

Serious or Rare Side Effects: - Angioedema - Severe skin rash (e.g., Stevens‑Johnson syndrome) - Suicidal thoughts or behavior - Respiratory depression, especially when combined with other CNS depressants - Blood dyscrasias such as neutropenia - Anaphylactic reactions

When prescribing Pregabalin, clinicians should consider several safety precautions to minimize risk.

Renal impairment: adjust dose based on creatinine clearance. Elderly patients: start at low dose and monitor for sedation. Suicidal ideation: monitor for mood changes and emergent thoughts. Pregnancy: category B, use only if benefit outweighs risk. Concomitant CNS depressants: avoid excessive sedation or respiratory depression. Driving and machinery: caution patients about impaired coordination. Store at ambient temperature: keep in original container, protect from moisture and heat.

Pregabalin can interact with other medicines, influencing its efficacy or safety profile.

Major Interactions (Avoid): - Opioids: combined use may cause profound respiratory depression and sedation. - Benzodiazepines or other CNS depressants: increased risk of profound drowsiness and impaired cognition. - Antidiabetic agents: may mask symptoms of hypoglycemia.

Moderate Interactions (Monitor Closely): - NSAIDs: may increase risk of peripheral edema. - Diuretics: monitor renal function and electrolyte balance. - Antihypertensives: possible additive blood pressure lowering. - Other antiepileptic drugs: may require dose adjustments. - MAO inhibitors: monitor for additive central nervous system effects.